EUVIMEDEUVIMED entdecken
Crossref

A deep drug prediction framework for viral infectious diseases using an optimizer-based ensemble of convolutional neural network: COVID-19 as a case study

A S Aruna, K R Remesh Babu, K Deepthi

Molecular Diversity · 2025

DOI: 10.1007/s11030-024-11003-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Diversity, 2025. Verfasst von A S Aruna und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Information Technology, Government Engineering College Palakkad, APJ Abdul Kalam Technological University, Palakkad, Kerala, 678633, India. …. Hauptthemen laut MEDLINE: Antiviral Agents, Convolutional Neural Networks, Drug Discovery, Drug Repositioning. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 81 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The SARS-CoV-2 outbreak highlights the persistent vulnerability of humanity to epidemics and emerging microbial threats, emphasizing the lack of time to develop disease-specific treatments. Therefore, it appears beneficial to utilize existing resources and therapies. Computational drug repositioning is an effective strategy that redirects authorized drugs to new therapeutic purposes. This strategy holds significant promise for newly emerging diseases, as drug discovery is a lengthy and expensive process. Through this study, we present an ensemble method based on the convolutional neural network integrated with genetic algorithm and deep forest classifier for virus-drug association prediction (CGDVDA). We generated feature vectors by combining drug chemical structure and virus genomic sequence-based similarities, and extracted prominent deep features by applying the convolutional neural network. The convoluted features are optimized using the genetic algorithm and classified using the ensemble deep forest classifier to predict novel virus-drug associations. The proposed method predicts drugs for COVID-19 and other viral diseases in the dataset. The model could achieve ROC-AUC scores of 0.9159 on fivefold cross-validation. We compared the performance of the model with state-of-the-art approaches and classifiers. The experimental results and case studies illustrate the efficacy of CGDVDA in predicting drugs against viral infectious diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsConvolutional Neural NetworksDrug DiscoveryDrug RepositioningHumansAlgorithmsCOVID-19 Drug TreatmentDeep LearningNeural Networks, ComputerPandemicsSARS-CoV-2

Stichwörter der Autor:innen

COVID-19Convolutional neural networkDeep forestDrug repurposingGenetic algorithm

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Dept. of Information Technology, Government Engineering College Palakkad, APJ Abdul Kalam Technological University, Palakkad, Kerala, 678633, India. aruna.arathi@gmail.com.
  • Department of Computer Science, College of Engineering Vadakara, Kozhikode, Kerala, 673105, India. aruna.arathi@gmail.com.
  • Dept. of Information Technology, Government Engineering College Palakkad, APJ Abdul Kalam Technological University, Palakkad, Kerala, 678633, India.
  • Department of Computer Science, Central University of Kerala (Govt. of India), Kasaragod, Kerala, 671320, India.

Zitieren

APA

Aruna, A. S., Babu, K. R. R., & Deepthi, K. (2025). A deep drug prediction framework for viral infectious diseases using an optimizer-based ensemble of convolutional neural network: COVID-19 as a case study. Molecular Diversity. https://doi.org/10.1007/s11030-024-11003-7

Vancouver

Aruna AS, Babu KRR, Deepthi K. A deep drug prediction framework for viral infectious diseases using an optimizer-based ensemble of convolutional neural network: COVID-19 as a case study. Molecular Diversity. 2025. doi:10.1007/s11030-024-11003-7

BibTeX
@article{Aruna2025,
  author = {Aruna, A S and Babu, K R Remesh and Deepthi, K},
  title = {A deep drug prediction framework for viral infectious diseases using an optimizer-based ensemble of convolutional neural network: COVID-19 as a case study},
  journal = {Molecular Diversity},
  year = {2025},
  doi = {10.1007/s11030-024-11003-7}
}
Kostenlos starten →